DOCSLIB.ORG

Coronavirus: Quello Che C'è Da Sapere – 19 Luglio 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Coronavirus: Quello Che C'è Da Sapere – 19 Luglio 2021 Coronavirus: quello che c’è da sapere – 19 luglio 2021 Sommario Quando è iniziata l’epidemia? ......................................2 Che cosa sono i test sierologici? a cosa servono? ................................26 Quando è arrivata in Italia? ..........................................2 Chi viene colpito dalla malattia Covid-19? ............................................26 A cosa è dovuta l’infezione? .........................................2 Quanto è letale il virus? Quali sono i fattori di rischio? .........................26 Quanto è diffusa l’epidemia? ....................................................................2 Quali sono le conseguenze a medio e lungo termine del Covid-19? .....31 Che cosa sono i coronavirus? ...................................................................2 Qual è l’origine del virus? .........................................................................4 Il virus può diventare endemico?............................................................32 Il virus può mutare? ..................................................................................4 Esiste un vaccino? ...................................................................................33 Come si trasmette l’infezione? ...............................................................10 Quali sono le terapie disponibili?............................................................48 I bambini sono più soggetti all’infezione? .............................................14 Quali sono i rischi sanitari legati all’epidemia? .....................................60 La malattia può essere trasmessa da una persona senza sintomi? .....17 Quali sono i rischi politici, economici e sociali legati all’epidemia? ....64 L’infezione può essere trasmessa dagli animali all’uomo (e Quali sono le nazioni più colpite dall’epidemia? ....................................66 viceversa)? ...............................................................................................18 Quanto è diffusa l’epidemia in Italia? .....................................................67 Come è possibile limitare la diffusione del virus? .................................19 È utile indossare la mascherina? ............................................................20 Quali misure sono state prese in Italia? .................................................70 Quanto dura l’immunità data dall’infezione o dal vaccino? ..................21 Possiamo viaggiare in Italia ed all’estero? ............................................76 I prodotti alimentari che acquistiamo e l’acqua potabile sono sicuri? .24 Dove è possibile trovare informazioni affidabili? ..................................78 Cosa fare se si sospetta di aver contratto l’infezione? ..........................24 Il Servizio Sanitario Nazionale e il ruolo dell’Istituto Nazionale Come viene diagnosticata la malattia Covid-19? ...................................24 Malattie Infettive “Lazzaro Spallanzani” ................................................79 Indice dei grafici e delle tabelle Incidenza del Covid-19 negli ultimi 14 giorni, casi per 100.000 Andamento della campagna vaccinale per regione, 19 luglio 2021 ......41 abitanti, settimane 26-27 (28 giugno - 11 luglio) .....................................1 Prime 10 nazioni per numero di nuovi casi, 19 luglio 2021 ...................44 Totale casi e decessi nel mondo, 19 luglio 2021 ......................................3 L’epidemia in Italia, 19 luglio 2021 .........................................................46 I quattro scenari possibili di inizio dell’epidemia ....................................5 Sperimentazioni cliniche approvate in Italia al 14 giugno 2020............49 Riepilogo delle principali varianti virali ....................................................6 Nuovi casi positivi in Italia nell’ultimo mese ..........................................54 Incidenza del Covid-19 in Europa, casi per 100.000 abitanti, settimane 26-27 (28 giugno - 11 luglio) ...................................................8 Tasso di positività dei tamponi effettuati in Italia ..................................61 Incremento giornaliero dei casi positivi nel mondo nell’ultimo mese ..11 Decessi Covid-19 per 100.000 abitanti in Italia, 19 luglio 2021 ............64 Strumenti di mitigazione per ridurre la trasmissione del virus .............12 Trend settimanale e mensile di casi e decessi nelle regioni OMS, 19 Decessi Covid-19 per milione di abitanti, 19 luglio 2021 .......................14 luglio 2021 ...............................................................................................66 Distribuzione dei casi nel mondo e in Europa, 19 luglio 2021 ...............16 Indicatori dell’epidemia per regione, 19 luglio 2021 ..............................68 Le dieci nazioni con più casi e decessi, 19 luglio 2021 .........................18 Fase 2: monitoraggio regionale 5 - 11 luglio 2021 .................................69 Casi positivi per fasce di età in Italia 18 giugno - 18 luglio ..................27 Mortalità in eccesso in Italia nel 2020-2021 rispetto alla media Decessi per fasce di età in Italia, 14 luglio 2021 ....................................28 2015-2019 ................................................................................................70 Casi e decessi giornalieri nelle aree più colpite, 19 luglio 2021............30 Decessi in Italia 1 maggio 2020 - 30 aprile 2021 a confronto con la Candidati vaccini in fase clinica, 19 luglio 2021 ....................................34 media 2015-2019 .....................................................................................71 Vaccini approvati per l’utilizzo, 19 luglio 2021.......................................37 Le dieci Regioni italiane con più casi, 19 luglio 2021 ............................73 Andamento delle vaccinazioni nel mondo, 19 luglio 2021 .....................39 Andamento dei decessi in Italia suddivisi per regione, gennaio 2020 Andamento della campagna vaccinale in Italia, 19 luglio 2021 ............40 - aprile 2021 .............................................................................................75 Per agevolare la lettura, nell’indice e nel documento sono evidenziate in giallo le parti aggiornate rispetto all’edizione precedente. https://www.inmi.it/aggiornamenti-coronavirus Incidenza del Covid-19 negli ultimi 14 giorni, casi per 100.000 abitanti, settimane 26-27 (28 giugno - 11 luglio) Fonte: ECDC a cura di Salvatore Curiale - direzione scientifica Istituto Nazionale Malattie infettive “Lazzaro Spallanzani” IRCCS – Roma – © INMI 2021 1 Quando è iniziata l’epidemia? ni dopo il primo caso accertato di positività a Codogno6. Il 31 dicembre 2019 le autorità sanitarie cinesi hanno reso nota la pre- Sempre a Milano, un gruppo di ricercatori dell’Università statale senza di un focolaio di sindrome febbrile, associata a polmonite di ori- ha condotto una analisi retrospettiva7 sui tamponi oro-faringei dei gine sconosciuta, tra gli abitanti di Wuhan, città di circa 11 milioni di casi sospetti di morbillo raccolti tra settembre 2019 e febbraio 2020 abitanti situata nella provincia di Hubei, nella Cina Centro-meridio- nell’ambito della rete di sorveglianza integrata morbillo e rosolia Mo- nale, alla confluenza tra il Fiume Azzurro e il fiume Han, a circa 1.100 RoNet. Dall’analisi è emersa la positività ad un gene del SARS-CoV-2 chilometri da Pechino, 800 da Shangai, 1.000 da Hong Kong. In un del campione di un bambino di 4 anni abitante nell’hinterland mila- primo momento il punto di partenza dell’infezione è stato identifica- nese e senza alcun link con la Cina, che il 21 novembre 2019 aveva to nel mercato del pesce e di altri animali vivi (c.d. “wet market”) di manifestato sintomi (tosse e rinite), il 30 novembre era stato porta- Huanan, al centro della città di Wuhan, che è stato chiuso il 1 genna- to al pronto soccorso con sintomi respiratori e vomito, il 1° dicembre io 2020. L’analisi del sangue di oltre 38.000 donatori sani a Wuhan e aveva avuto un’eruzione cutanea simile a quella che si manifesta con il in altre due città cinesi, Shenzen (estremo sud) e Shijiazhuang (estre- morbillo, e il 5 dicembre aveva effettuato il tampone oro-faringeo per mo nord) tra gennaio ed aprile 2020) ha evidenziato una prevalenza, la diagnosi clinica del sospetto morbillo. ovvero una percentuale di persone che avevano sviluppato anticor- pi contro il virus SARS-CoV-2, del 2,66% a Wuhan, dello 0,033% a A cosa è dovuta l’infezione? Shenzen e dello 0,0028% a Shijiazhuang1. È ormai confermato però Il 7 gennaio 2020 è stato isolato l’agente patogeno responsabile dell’e- che il mercato è stato soltanto il primo amplificatore dell’infezione, pidemia: si tratta di un nuovo betacoronavirus, che l’OMS ha de- iniziata settimane prima. Nel corso di una conferenza stampa svoltasi nominato SARS-CoV-2, ad indicare la similarità con il virus SARS- a Wuhan il 9 febbraio 2021 con gli esperti dell’Organizzazione Mon- CoV, che nel 2002-2003 causò una epidemia globale con 8.096 casi diale della Sanità (OMS) chiamati ad indagare sull’origine dell’epide- confermati e 774 decessi. L’OMS ha denominato Covid-19 la malat- mia, si è appreso infatti che il primo caso di Covid-19 a Wuhan è da- tia causata dal virus. tato 8 dicembre 2019 e non aveva alcuna relazione con il mercato di Huanan2. Ma la data dello spillover, ovvero della prima trasmissione Quanto è diffusa l’epidemia? del virus dall’animale all’uomo, è con ogni probabilità ancora prece- In base ai dati forniti giornalmente dall’OMS8, ad oggi (19
Load more

Recommended publications
  • Vaccination What Is Vaccination?
    VACCINATION WHAT IS VACCINATION? Vaccination is a simple, safe, and effective way of protecting people against harmful diseases, before they come into contact with them. Makes your immune system stronger. Vaccines train your immune system to create antibodies. SOURCE : World Health Organization Why You Should Get Vaccinated? COVID-19 vaccines are safe and effective. When we get vaccinated, we aren’t just protecting ourselves, but also those around us. Helps to reduce the spread of disease. SOURCE : World Health Organizations Are Vaccines Safe? Vaccination is safe. The benefits of vaccination greatly outweigh the risks, and many more illnesses and deaths would occur without vaccines. SOURCE : World Health Organization Side Effects Of Vaccines Like any medicine, vaccines can cause mild side effects, such as a low- grade fever, or pain or redness at the injection site. Severe or long-lasting side effects are extremely rare. Vaccines are continually monitored for safety, to detect rare adverse events. SOURCE : World Health Organization Types Of Vaccines In India 1. Covaxin 2. Covishield 3. ZyCoV-D 4. Sputnik 5. BBV154 – Intranasal Vaccine 6. Moderna 7. Pfizer SOURCE : Indian Council Of Medical Research Details About Covaxin Covaxin is an inactivated vaccine which means that it is made up of killed coronaviruses, making it safe to be injected into the body. When administered, immune cells can still recognise the dead virus, prompting the immune system to make antibodies against the pandemic virus. The two doses are given four weeks apart. The vaccine can be stored at 2C to 8C. SOURCE : BBC Details About Covishield The vaccine is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees.
    [Show full text]
  • 0 January to July 2021
    0 www.journalsofindia.com January to July 2021 SCIENCE & TECH ............................................................................................................................................................... 6 1. REUSABLE LAUNCH VEHICLE TECHNOLOGY DEMONSTRATION PROGRAMME(RLV-TD) ................................................. 6 2. GAGANYAAN MISSION ..................................................................................................................................................... 6 3. MARS ORBITER MISSION (MOM) ..................................................................................................................................... 6 4. CHANDRAYAAN MISSION................................................................................................................................................. 7 5. SOLAR MISSION ............................................................................................................................................................... 8 6. ARTEMIS ACCORD ............................................................................................................................................................ 9 7. NATIONAL MISSION ON INTERDISCIPLINARY CYBER-PHYSICAL SYSTEM (NMICPS) ....................................................... 10 8. SMART ANTI-AIRFIELD WEAPON (SAAW) ...................................................................................................................... 10 9. AQUAPONICS ................................................................................................................................................................
    [Show full text]
  • Molecular Analysis of SARS-Cov-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level
    pathogens Article Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level Malik Sallam 1,2,* and Azmi Mahafzah 1,2 1 Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan; [email protected] 2 Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan * Correspondence: [email protected]; Tel.: +962-79-184-5186 Abstract: The rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is manifested by the emergence of an ever-growing pool of genetic lineages. The aim of this study was to analyze the genetic variability of SARS-CoV-2 in Jordan, with a special focus on the UK variant of concern. A total of 579 SARS-CoV-2 sequences collected in Jordan were subjected to maximum likelihood and Bayesian phylogenetic analysis. Genetic lineage assignment was undertaken using the Pango system. Amino acid substitutions were investigated using the Protein Variation Effect Analyzer (PROVEAN) tool. A total of 19 different SARS-CoV-2 genetic lineages were detected, with the most frequent being the first Jordan lineage (B.1.1.312), first detected in August 2020 (n = 424, 73.2%). This was followed by the second Jordan lineage (B.1.36.10), first detected in September 2020 (n = 62, 10.7%), and the UK variant of concern (B.1.1.7; n = 36, 6.2%). In the spike gene region, Citation: Sallam, M.; Mahafzah, A. the molecular signature for B.1.1.312 was the non-synonymous mutation A24432T resulting in a Molecular Analysis of SARS-CoV-2 deleterious amino acid substitution (Q957L), while the molecular signature for B.1.36.10 was the Genetic Lineages in Jordan: Tracking synonymous mutation C22444T.
    [Show full text]
  • Bcpct]Ttsbc^Prc U^A Dq[XRV^^S
    6 < %()(=#%% 53%7==,>3='$()6(=#%% (#-'>3='$()6(=#%% $'()"*$+&,- %( !"# $$%& 2(*3-% (566)(37)% 3 0 4 $5 3 $1 2 0 .8 9 8 ++0 0 .:; . !" . / 01 $ %'( $) '# *' it for the last eight to nine notable achievements to its months, “where is the UN in name in the 75 years of its aking a strong case for a this joint fight. Where is the experience, including the pre- Msignificant role for India effective response.” vention of a third world war, in the United Nations, Prime Focussing on a more “we can’t deny terrorist attacks 0 Minister Narendra Modi on prominent role for India in the shook the world”. Saturday stressed the need for UN and fight against corona, “We have successfully ne of the oldest partners changes in the international the Prime Minister avoided avoided a third world war but Oof the BJP — the body and questioned its posi- making any reference to ongo- we cannot deny many wars Shiromani Akali Dal — which tion in fighting the coron- ing tension at the Line of happened, many civil wars has been with it through thick avirus pandemic. Actual Control (LAC) and happened. Terrorist attack and thin for decades, finally He also assured the global frosty ties with Pakistan in his shook the world. Blood was quit the National Democratic Q community that India will pro- 20-minute speech. He also did spilled. Those were killed were Alliance (NDA) on Saturday, vide corona vaccine to the not respond to Pakistan Prime like you and me. Children left signaling a complete political world as it is the world’s biggest Minister Imran Khan’s remarks the world prematurely,” he said.
    [Show full text]
  • REALM Research Briefing: Vaccines, Variants, and Venitlation
    Briefing: Vaccines, Variants, and Ventilation A Briefing on Recent Scientific Literature Focused on SARS-CoV-2 Vaccines and Variants, Plus the Effects of Ventilation on Virus Spread Dates of Search: 01 January 2021 through 05 July 2021 Published: 22 July 2021 This document synthesizes various studies and data; however, the scientific understanding regarding COVID-19 is continuously evolving. This material is being provided for informational purposes only, and readers are encouraged to review federal, state, tribal, territorial, and local guidance. The authors, sponsors, and researchers are not liable for any damages resulting from use, misuse, or reliance upon this information, or any errors or omissions herein. INTRODUCTION Purpose of This Briefing • Access to the latest scientific research is critical as libraries, archives, and museums (LAMs) work to sustain modified operations during the continuing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. • As an emerging event, the SARS-CoV-2 pandemic continually presents new challenges and scientific questions. At present, SARS-CoV-2 vaccines and variants in the US are two critical areas of focus. The effects of ventilation-based interventions on the spread of SARS-CoV-2 are also an interest area for LAMs. This briefing provides key information and results from the latest scientific literature to help inform LAMs making decisions related to these topics. How to Use This Briefing: This briefing is intended to provide timely information about SARS-CoV-2 vaccines, variants, and ventilation to LAMs and their stakeholders. Due to the evolving nature of scientific research on these topics, the information provided here is not intended to be comprehensive or final.
    [Show full text]
  • Cuba: One Year Into the Pandemic
    BULLETIN OF PAHO/WHO IN CUBA Vol. 25 No.1 JANUARY-MARCH 2021 CUBA: ONE YEAR INTO THE PANDEMIC 04 43 46 50 OUR NEWS: NOTEWORTHY: OVER A STORY A CUP OF TO TELL: Interview Benefits with Cuba's of a Cúrcumal onga COFFEE Dr. Ricardo Minister pdroject uring WITH… Pereda González: of Public Health, thep andemic Coordinator of Dr. José Angel Concepción the COVID-19 Clinical Portal Miranda Campa Experts Commission Huergo Pathways to Health is a bulletin prepared by the office of the Pan American Health Organization/World Health Organization EDITORIAL (PAHO/WHO) in Cuba. Its main aim is to share the most important aspects of the On March 11, 2020, the Director-General of the World Health Representation's technical cooperation with Organization (WHO) declared the novel coronavirus a pandemic, the country's Ministry of Public Health which at the time already affected 114 nations. Coincidentally, (MINSAP) and other institutions. that same day, the Pedro Kourí Tropical Medicine Institute (IPK) in Havana confirmed the first COVID-19 cases in Cuba. At the one-year anniversary of the pandemic in Cuba, this issue is dedicated to One year into the pandemic, more than 115 million cases and close to 2.6 million deaths have been reported from the disease systematically review key aspects of the worldwide. About half of both these cases and deaths have been national response over the last months. In registered in the Americas, with results differing according to how particular, it includes an interview with the well the response has been organized, how robust the healthcare Minister of Public Health, Dr.
    [Show full text]
  • Microsoft Outlook
    Morris, Max From: Morris, Max Sent: Monday, March 22, 2021 11:38 PM To: Morris, Max Subject: 03/22/2021 Coronavirus Daily Recap This email is provided for informational, non-commercial purposes only. Use or reliance on the information contained in this email is at your sole risk. This email is not provided by or affiliated in any way with Ally Financial Inc. These updates are being shared to multiple organizations, individuals and lists who/which are bcc’d. Best effort we are sending Daily updates during the business week, typically in the evening, a Weekend Recap on Monday mornings, and any significant breaking news events provided anytime. Please note some numbers included in the Statistics and news stories come from various sources and so can vary as they are constantly changing and not reported at the same time. All communications are TLP GREEN and can be shared freely. Know someone who might want to be added to our Updates? Of course ask them first, and then have them send us an email to [email protected]. Live the message, share the message: Be safe – Stay home and limit travel as much as possible, self-quarantine if you or any members of your family are or may be sick, if you go out wear your mask – the right way, ensure safe social distancing, and practice good hygiene – wash your hands, avoid touching your face, and sanitize used items and surfaces. Need to find a vaccine? Here are a few good sites and resources we have come across that may help: CDC Vaccine Finder – https://vaccinefinder.org/ [Free government website where users can search for pharmacies and providers that offer vaccinations, currently limited number of states but expanding] Dr.
    [Show full text]
  • COVID-19 Vaccination Programme: Information for Healthcare Practitioners
    COVID-19 vaccination programme Information for healthcare practitioners Republished 6 August 2021 Version 3.10 1 COVID-19 vaccination programme: Information for healthcare practitioners Document information This document was originally published provisionally, ahead of authorisation of any COVID-19 vaccine in the UK, to provide information to those involved in the COVID-19 national vaccination programme before it began in December 2020. Following authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency being given to the COVID-19 Vaccine Pfizer BioNTech on 2 December 2020, the COVID-19 Vaccine AstraZeneca on 30 December 2020 and the COVID-19 Vaccine Moderna on 8 January 2021, this document has been updated to provide specific information about the storage and preparation of these vaccines. Information about any other COVID-19 vaccines which are given regulatory approval will be added when this occurs. The information in this document was correct at time of publication. As COVID-19 is an evolving disease, much is still being learned about both the disease and the vaccines which have been developed to prevent it. For this reason, some information may change. Updates will be made to this document as new information becomes available. Please use the online version to ensure you are accessing the latest version. 2 COVID-19 vaccination programme: Information for healthcare practitioners Document revision information Version Details Date number 1.0 Document created 27 November 2020 2.0 Vaccine specific information about the COVID-19 mRNA 4 Vaccine BNT162b2 (Pfizer BioNTech) added December 2020 2.1 1.
    [Show full text]
  • Editorial 10.5005/Ijmb-24-3-Iv
    Editorial 10.5005/ijmb-24-3-iv COVID-19 Vaccines: Lets Go for It SARS CoV-2, also christened as COVID-19 is an acute respiratory illness caused by a novel coronavirus which originated from Wuhan China in 2019 and within a short span affected virtually each and every country around the globe, throwing healthcare preparedness and economy out of gear. The world was faced with a pandemic leading to overcrowded hospitals and overflowing mortuaries. Lockdowns imposed in countries jeopardized routine life never to normalize again. India has been among the top three countries with the maximum number of afflicted people. Thankfully , our statistics with respect to mortality is better as compared to the western world. The last year 2020 was completely COVIDISED if we may say so. The world economy is in doldrums and the health infrastructure is overstretched and fatigued. Everytime we feel that the disease is under control, the virus cleverly mutates to become more infective and develops increased ability to escape the immune surveillance. Efforts to develop a vaccine against this scourge were initiated at a war footing across the globe. A number of vaccines were approved for emergency use since the scientific committee didn’t have the time to wait further. In India, two vaccines- Covaxin and Covishield have been approved by the Government of India for mass vaccination. The mammoth program was initiated with first preference for the healthcare workers and frontline warriors. In the next phases, elderly population followed by the rest of the population in a phased manner was planned. It is really incredible and praiseworthy about the immaculate planning and implementation of the initiative in our country where the diversity is both a boon as well as bane.
    [Show full text]
  • Progress in the Development of Potential Therapeutics and Vaccines Against COVID-19 Pandemic
    Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 5 Issue 7 July 2021 Review Article Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic Abhishek Kumar Yadav, Shubham Kumar and Vikramdeep Monga* Received: May 02, 2021 Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, Published: June 09, 2021 India © All rights are reserved by Vikramdeep *Corresponding Author: Vikramdeep Monga, Department of Pharmaceutical Monga., et al. Chemistry, ISF College of Pharmacy, Moga, Punjab, India. Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 or coronavirus disease 2019 and the same has been declared as a global pandemic by WHO which marked the third introduction of a virulent coronavirus into human society. This a threat to human life worldwide. Considerable efforts have been made for developing effective and safe drugs and vaccines against is a highly pathogenic human coronavirus in which pneumonia of unknown origin was identified in China in December 2019 and is SARS-CoV-2. The current situation and progress in the development of various therapeutic candidates including vaccines in preclini- cal and clinical studies have been described in the manuscript. Until now, many people have been infected with this lethal virus, and a lot of people have died from this COVID-19. This viral disease spreads by coming in contact with an infected person. Understand- ing of SARS-CoV-2 is growing in relation to its epidemiology, virology, and clinical management strategies. Till date, very few drugs or vaccines have been developed or approved for the treatment of this deadly disease of COVID-19 and many candidates are under the clinical development pipeline.
    [Show full text]
  • The Falling Netanyahu Takes Down a Cantankerous Political Class
    WWW.TEHRANTIMES.COM I N T E R N A T I O N A L D A I L Y 8 Pages Price 50,000 Rials 1.00 EURO 4.00 AED 43rd year No.13954 Saturday MAY 29, 2021 Khordad 8, 1400 Shawwal 17, 1442 Elections is Brighton’s Alireza Steel ingot export Germany recognizes competition to Jahanbakhsh to decide rises 135% in colonial-era massacres in serve people Page 2 on his future Page 3 a month on year Page 4 Namibia as genocide Page 5 Unity is the secret behind the Resistance’s victories: Amir-Abdollahian TEHRAN - Hossein Amir-Abdollahian, the resistance and steadfastness victory could special aide to the speaker of the Iranian be achieved. This victory sent an important Parliament on international affairs, has re- message that the Zionist enemy only under- flected on the secret behind the recent victory stands the language of force and resistance,” of the Palestinian resistance against Israel. he told the Lebanese Al-Ahed News. Amir-Abdollahian said the 2006 victo- The Iranian diplomat added, “This ry of the Lebanese resistance movement victory and other victories achieved by against Israel raised faith in the resistance the resistance, especially the victory of and sent a message that Israel understands July 2006, were achieved in light of the only the language of power. unity of the Lebanese people and the gold- “The flight of the Zionist entity from en equation in Lebanon – the army, the southern Lebanon raised faith in the resist- people, and the resistance. Crabs in ance among the Lebanese, and that through Continued on page 3 Tehran, Moscow confer on joint investment in agricultural sector TEHRAN – Iranian Agriculture Minis- investment in various agricultural fields.
    [Show full text]
  • Bjpworker Shot PM Modi Chairs CCS Meeting to Dead by Militants in Cases, One Death Review Situation in Afghanistan JAMMU RISING Gus) in the Union Territory
    JAMMU, WEDNESDAY, AUGUST 18, 2021 JAMMU RISING NEWS P-3 NEWS P-5 NEWS P-12 NATIONAL P-8 SPORT P-7 Advisor 9 Doda youth 36 Keralites T20 World Cup: Bhatnagar get Ramban Admin felicitates DPO stranded in Kabul conducts commercial ICC releases with ‘EX- seek urgent help to vehicles schedule, India- extensive CELLENT return home; CM tour of under Pakistan match CIVILSER- reaches out to Jammu MUMKIN VICES AWARD’ on October 24 city scheme Centre Price: Rs.1 | Page 12 | Vol. No.: 11 | Issue No: 191 Postal Registration No. JK-458/16-18 epaper.dailyjammurising.in RNI No: JKENG/2011/40494 BRIEF NEWS J&K reports 83 COVID-19 BJPworker shot PM Modi chairs CCS meeting to dead by militants in cases, one death review situation in Afghanistan JAMMU RISING gus) in the union territory. The Bulletin also informs J&K’s Kulgam JAMMU, AUG 17 The Government on Tues- that no new confirmed case ABJP worker was shot dead NEW DELHI,AUG 17 tional status of Kabul airport. Jammu and Kashmir day informed that 83 new of Mucormycosis has been by militants in Brazloo area of Prime Minister Narendra This has been discussed at recorded 83 fresh COVID- positive cases of novel reported today, thus the total South Kashmir’s Kulgam dis- Modi chaired a meeting of high levels with our partners, 19 cases and one fatality on Corona virus (COVID-19), number of confirmed cases trict today. the Cabinet Committee on including by EAM with the Tuesday, pushing the union 38 from Jammu division and remains 42 in the UT of Militants fired upon BJP In- Security on Tuesday to re- US Secretary of State.
    [Show full text]